Survodutide
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Boehringer Ingelheim · Phase 3 · Not yet recruiting · Enrollment 600
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Survodutide arm | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo arm | Obesity or overweight | n/r | n/r | n/r | n/r |